Lisata Therapeutics, Inc. (LSTA)
NASDAQ · Manufacturing · Pharmaceutical preparations
LSTA price, last 12 months
Key stats
- Previous close
- $0.9801
- Open
- $0.9507
- Day range
- $0.8639 – $0.9742
- 52-week range
- $0.8500 – $5.07
- Volume
- 233.2K
- Avg volume (20 days)
- 143.8K
- Market cap
- $13.1M
Performance
Technicals and fundamentals
About Lisata Therapeutics, Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $13.1M